Thymosin Alpha-1 Restores Immunity After Stem Cell Transplant: Fighting Post-Transplant Infections

Thymosin alpha-1 enhanced immune reconstitution after haploidentical hematopoietic transplantation, reducing infection risk during the critical immune-depleted period — peptide immunotherapy for transplant patients.

Perruccio, Katia et al.·Annals of the New York Academy of Sciences·2010·
RPEP-016712010RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Not classified
Evidence
Not graded
Sample
Not reported

What This Study Found

Thymosin alpha-1 enhanced immune reconstitution after haploidentical hematopoietic transplantation, reducing infection risk during the critical immune-depleted period — peptide immunotherapy for transplant patients.

Key Numbers

How They Did This

research study.

Why This Research Matters

Relevant for peptide research.

The Bigger Picture

Advances peptide research.

What This Study Doesn't Tell Us

See abstract.

Questions This Raises

  • ?Further research needed.

Trust & Context

Key Stat:
Key finding Thymosin alpha-1 enhanced immune reconstitution after haploidentical hematopoietic transplantation, reducing infection risk during the critical immune
Evidence Grade:
emerging evidence.
Study Age:
Published in 2010.
Original Title:
Thymosin alpha1 to harness immunity to pathogens after haploidentical hematopoietic transplantation.
Published In:
Annals of the New York Academy of Sciences, 1194, 153-61 (2010)
Database ID:
RPEP-01671

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Frequently Asked Questions

What was studied?

Thymosin Alpha-1 Restores Immunity After Stem Cell Transplant: Fighting Post-Transplant Infections

What was found?

Thymosin alpha-1 enhanced immune reconstitution after haploidentical hematopoietic transplantation, reducing infection risk during the critical immune-depleted period — peptide immunotherapy for transplant patients.

Read More on RethinkPeptides

Related articles coming soon.

Cite This Study

RPEP-01671·https://rethinkpeptides.com/research/RPEP-01671

APA

Perruccio, Katia; Bonifazi, Pierluigi; Topini, Fabiana; Tosti, Antonella; Bozza, Silvia; Aloisi, Teresa; Carotti, Alessandra; Aversa, Franco; Martelli, Massimo F; Romani, Luigina; Velardi, Andrea. (2010). Thymosin alpha1 to harness immunity to pathogens after haploidentical hematopoietic transplantation.. Annals of the New York Academy of Sciences, 1194, 153-61. https://doi.org/10.1111/j.1749-6632.2010.05486.x

MLA

Perruccio, Katia, et al. "Thymosin alpha1 to harness immunity to pathogens after haploidentical hematopoietic transplantation.." Annals of the New York Academy of Sciences, 2010. https://doi.org/10.1111/j.1749-6632.2010.05486.x

RethinkPeptides

RethinkPeptides Research Database. "Thymosin alpha1 to harness immunity to pathogens after haplo..." RPEP-01671. Retrieved from https://rethinkpeptides.com/research/perruccio-2010-thymosin-alpha1-to-harness

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.